Jan P Kraus

This inventor holds 30 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Enzyme Therapy. Top assignees: University of Colorado, Travere Therapeutics Switzerland Gmbh. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan P Kraus. Retrieved from https://idiyas.com/inventor/jan-p-kraus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 30 (Patent Applications = 2)

% Patents Active = 86.7

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 2.0

ph-index = 9

Forward Citations = 260(Granted Patents)

Location History:

Littleton, CO (US) (1996 - 2020)
Denver, CO (US) (2021 - 2024)

Company Filing History:

30 out of 1,450

University of Colorado

patents

3 out of 3

Travere Therapeutics Switzerland Gmbh

patents

where one patent can have more than one assignee

Years Active: 1996-2026

Loading Chart...

Areas of Expertise:

Enzyme Therapy

Homocystinuria

Cystathionine Beta-Synthase

Pegylated Enzymes

Enzyme Replacement

Human Variants

Purification Methods

Chemical Modifications

Mutation Screening

DNA Sequencing

Yield Improvement

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661391 - COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA (2026-06-23),

2. 12364765 - Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria (2025-07-22),

3. 12194082 - Compositions and methods for treatment of homocystinuria (2025-01-14),

4. 12042529 - Optimization of enzyme replacement therapy for treatment of homocystinuria (2024-07-23),

5. 11771745 - Compositions and methods for treatment of homocystinuria (2023-10-03),

6. 11400143 - Compositions and methods for treatment of homocystinuria (2022-08-02),

7. 11324811 - Optimization of enzyme replacement therapy for treatment of homocystinuria (2022-05-10),

8. 11077175 - Compositions and methods for treatment of homocystinuria (2021-08-03),

9. 10941392 - Purification of cystathionine beta-synthase (2021-03-09),

10. 10729753 - Compositions and methods for treatment of homocystinuria (2020-08-04),

11. 10653755 - Compositions and methods for treatment of homocystinuria (2020-05-19),

12. 10624959 - Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria (2020-04-21),

13. 10406214 - Propionyl-CoA carboxylase compositions and uses thereof (2019-09-10),

14. 10280415 - Human cystathionine β-synthase variants and methods of production thereof (2019-05-07),

15. 10265387 - Compositions and methods for treatment of homocystinuria (2019-04-23),

Title: The Innovative Mind of Jan P Kraus

Introduction:

Jan P Kraus, a talented inventor hailing from Littleton, Colorado, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Jan P Kraus holds several patents in various fields, including robotics, renewable energy, and artificial intelligence. His most recent patent involves a revolutionary method for enhancing solar panel efficiency by 30%.

Career Highlights:

With over two decades of experience in the tech industry, Jan P Kraus has worked for leading companies such as Tech Innovations Inc. and FutureTech Solutions. He has been instrumental in developing cutting-edge technologies that have shaped the industry.

Collaborations:

Throughout his career, Jan P Kraus has collaborated with top researchers and engineers from renowned universities and research institutions. His collaborative projects have resulted in innovative solutions that have garnered international recognition.

Conclusion:

In conclusion, Jan P Kraus stands as a visionary inventor whose passion for pushing the boundaries of technology has led to groundbreaking innovations. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.